REQUEST A DEMO
Total
USD $0.00
Search more companies

Zetta Pharma Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Zetta Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Zetta Pharma Company Limited is based in Thailand, with the head office in Nakhon Pathom. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on July 07, 2026. 84 (estimated) employees currently work for Zetta Pharma Company Limited. There was a net sales revenue drop of 33.57% reported in Zetta Pharma Company Limited’s latest financial highlights for 2025. A growth of 8.28% was recorded in its total assets. In, 2025, the company’s net profit margin decreased by 0.01%.

Headquarters
19/1 Moo 1
Nakhon Pathom; Central Thailand; Postal Code: 73000

Contact Details: Purchase the Zetta Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Zetta Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Zetta Pharma Company Limited report to view the information.
Incorporation Date:
July 07, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Zetta Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-33.57%
Total Operating Revenue
-33.57%
Operating Profit
-5.97%
Net Profit/Loss for the Period
-43.51%
Total Assets
8.28%
Total Equity
0.04%
Operating Profit Margin
3.76%
Net Profit Margin
-0.01%
Return on Equity (ROE)
-0.04%
Debt / Equity
15.4%
Quick Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?